Editorial
|
|
|
|
|
A cool head is needed when dealing with industry hype and fads
|
|
|
|
New Products
|
|
|
|
|
Very slow piperaquine elimination: cardiovascular risks and interactions
|
|
|
|
|
|
|
|
|
|
Metastatic colorectal cancer in treatment failure: may prolong survival by a few weeks
|
|
|
|
|
|
|
|
|
|
Choose better-documented immunosuppressant combinations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check cardiovascular status again on treatment resumption
|
|
|
|
Adverse Effects
|
|
|
|
|
Involving patients in treatment is essential
|
|
|
|
|
|
|
|
|
|
|
|
Safe disposal of used patches is a must
|
|
|
|
|
|
|
|
|
|
No safer than benzodiazepines
|
|
|
|
Reviews
|
|
|
|
|
Too many uncertainties, even for smokers
|
|
|
|
|
|
|
|
|
|
A large-scale study confirms the high risk
|
|
|
|
Outlook
|
|
|
|
|
Read up and think hard before prescribing
|
|
|
|
|
|
|
|
|
|
|
|
French policy-makers have overlooked patients' interest
|
|
|
|
|
|